118 related articles for article (PubMed ID: 1719394)
1. The Walker 256 carcinoma: a cell type inherently sensitive only to those difunctional agents that can form DNA interstrand crosslinks.
Knox RJ; Lydall DA; Friedlos F; Basham C; Rawlings CJ; Roberts JJ
Mutat Res; 1991 Nov; 255(3):227-40. PubMed ID: 1719394
[TBL] [Abstract][Full Text] [Related]
2. The effect of monofunctional or difunctional platinum adducts and of various other associated DNA damage on the expression of transfected DNA in mammalian cell lines sensitive or resistant to difunctional agents.
Knox RJ; Lydall DA; Friedlos F; Basham C; Roberts JJ
Biochim Biophys Acta; 1987 Apr; 908(3):214-23. PubMed ID: 3567197
[TBL] [Abstract][Full Text] [Related]
3. The unique sensitivity of Walker rat tumour cells to difunctional agents is associated with a failure to recover from inhibition of DNA synthesis and increased chromosome damage.
Roberts JJ; Friedlos F; Scott D; Ormerod MG; Rawlings CJ
Mutat Res; 1986 Sep; 166(2):169-81. PubMed ID: 3762563
[TBL] [Abstract][Full Text] [Related]
4. Walker rat carcinoma cells are exceptionally sensitive to cis-diamminedichloroplatinum(II) (cisplatin) and other difunctional agents but not defective in the removal of platinum-DNA adducts.
Rawlings CJ; Roberts JJ
Mutat Res; 1986 Sep; 166(2):157-68. PubMed ID: 3762562
[TBL] [Abstract][Full Text] [Related]
5. A comparative analysis of drug-induced DNA effects in a nitrogen mustard resistant cell line expressing sensitivity to nitrosoureas.
Dean SW; Johnson AB; Tew KD
Biochem Pharmacol; 1986 Apr; 35(7):1171-6. PubMed ID: 2938589
[TBL] [Abstract][Full Text] [Related]
6. CB 1954 (2,4-dinitro-5-aziridinyl benzamide) becomes a DNA interstrand crosslinking agent in Walker tumour cells.
Roberts JJ; Friedlos F; Knox RJ
Biochem Biophys Res Commun; 1986 Nov; 140(3):1073-8. PubMed ID: 3778483
[TBL] [Abstract][Full Text] [Related]
7. Selection of nitrogen mustard resistance in a rat tumor cell line results in loss of guanine-O6-alkyl transferase activity.
Dean SW; Gibson NW; Tew KD
Mol Pharmacol; 1986 Jul; 30(1):77-80. PubMed ID: 3724747
[TBL] [Abstract][Full Text] [Related]
8. Correlation of increased acetate binding with alkylating agent resistance in Walker and Yoshida tumor cells.
Pinsky SD
Biochem Pharmacol; 1982 Dec; 31(24):3991-6. PubMed ID: 7159476
[TBL] [Abstract][Full Text] [Related]
9. C-banding of two Walker 256 rat carcinoma cell lines sensitive and resistant to bifunctional mustards.
Hartley-Asp B; Billström A; Tew KD
Anticancer Res; 1987; 7(2):209-13. PubMed ID: 3592633
[TBL] [Abstract][Full Text] [Related]
10. A new cytotoxic, DNA interstrand crosslinking agent, 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide, is formed from 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by a nitroreductase enzyme in Walker carcinoma cells.
Knox RJ; Friedlos F; Jarman M; Roberts JJ
Biochem Pharmacol; 1988 Dec; 37(24):4661-9. PubMed ID: 3202902
[TBL] [Abstract][Full Text] [Related]
11. Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells.
Parekh H; Simpkins H
Cancer Chemother Pharmacol; 1996; 37(5):457-62. PubMed ID: 8599869
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.
Knox RJ; Friedlos F; Lydall DA; Roberts JJ
Cancer Res; 1986 Apr; 46(4 Pt 2):1972-9. PubMed ID: 3512077
[TBL] [Abstract][Full Text] [Related]
13. Selective cytotoxicity of haloethylnitrosoureas in a carcinoma cell line resistant to bifunctional nitrogen mustards.
Tew KD; Wang AL
Mol Pharmacol; 1982 May; 21(3):729-38. PubMed ID: 7110120
[TBL] [Abstract][Full Text] [Related]
14. A new anticancer platinum compound, (-)-(R)-2-aminomethyl-pyrrolidine(1,1-cyclobutanedicarboxylato) platinum(II): DNA interstrand crosslinking, repair and lethal effects in normal human, Fanconi's anaemia and xeroderma pigmentosum cells.
Fujiwara Y; Nakamura M; Yokoo S
Br J Cancer; 1993 Jun; 67(6):1285-92. PubMed ID: 8512813
[TBL] [Abstract][Full Text] [Related]
15. The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT).
Knox RJ; Friedlos F; Boland MP
Cancer Metastasis Rev; 1993 Jun; 12(2):195-212. PubMed ID: 8375021
[TBL] [Abstract][Full Text] [Related]
16. Ultraviolet irradiation produces cytotoxic synergy and increased DNA interstrand crosslinking with cis- and trans-diamminedichloroplatinum(II).
Swinnen LJ; Fisher SG; Erickson LC
Carcinogenesis; 1989 Aug; 10(8):1465-70. PubMed ID: 2752520
[TBL] [Abstract][Full Text] [Related]
17. Acquired drug resistance is accompanied by modification in the karyotype and nuclear matrix of a rat carcinoma cell line.
Tew KD; Moy BC; Hartley-Asp B
Exp Cell Res; 1983 Dec; 149(2):443-50. PubMed ID: 6641811
[TBL] [Abstract][Full Text] [Related]
18. The properties of total adducts and interstrand crosslinks in the DNA of cells treated with CB 1954. Exceptional frequency and stability of the crosslink.
Friedlos F; Quinn J; Knox RJ; Roberts JJ
Biochem Pharmacol; 1992 Mar; 43(6):1249-54. PubMed ID: 1562278
[TBL] [Abstract][Full Text] [Related]
19. Carbamoylation of glutathione reductase and changes in cellular and chromosome morphology in a rat cell line resistant to nitrogen mustards but collaterally sensitive to nitrosoureas.
Tew KD; Kyle G; Johnson A; Wang AL
Cancer Res; 1985 May; 45(5):2326-33. PubMed ID: 3986776
[TBL] [Abstract][Full Text] [Related]
20. Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapy.
Wynne P; Newton C; Ledermann JA; Olaitan A; Mould TA; Hartley JA
Br J Cancer; 2007 Oct; 97(7):927-33. PubMed ID: 17848946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
